358 related articles for article (PubMed ID: 26329786)
1. 18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination.
Zhou J; Cai W; Jin M; Xu J; Wang Y; Xiao Y; Hao L; Wang B; Zhang Y; Han J; Huang R
Sci Rep; 2015 Sep; 5():13713. PubMed ID: 26329786
[TBL] [Abstract][Full Text] [Related]
2. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
3. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
5. Leonurine suppresses neuroinflammation through promoting oligodendrocyte maturation.
Jin M; Li Q; Gu Y; Wan B; Huang J; Xu X; Huang R; Zhang Y
J Cell Mol Med; 2019 Feb; 23(2):1470-1485. PubMed ID: 30556290
[TBL] [Abstract][Full Text] [Related]
6. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Savarin C; Hinton DR; Valentin-Torres A; Chen Z; Trapp BD; Bergmann CC; Stohlman SA
J Neuroinflammation; 2015 Apr; 12():79. PubMed ID: 25896970
[TBL] [Abstract][Full Text] [Related]
8. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
9. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
Front Immunol; 2020; 11():571844. PubMed ID: 33193354
[TBL] [Abstract][Full Text] [Related]
10. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM
Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203
[TBL] [Abstract][Full Text] [Related]
11. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
[TBL] [Abstract][Full Text] [Related]
12. Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis.
Bao Z; Hao J; Li Y; Feng F
Mol Med Rep; 2019 Dec; 20(6):5190-5196. PubMed ID: 31702807
[TBL] [Abstract][Full Text] [Related]
13. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Yin LL; Lin LL; Zhang L; Li L
Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
[TBL] [Abstract][Full Text] [Related]
14. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
Guo X; Nakamura K; Kohyama K; Harada C; Behanna HA; Watterson DM; Matsumoto Y; Harada T
Neurosci Res; 2007 Dec; 59(4):457-66. PubMed ID: 17920148
[TBL] [Abstract][Full Text] [Related]
16. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair.
Geladaris A; Torke S; Saberi D; Alankus YB; Streit F; Zechel S; Stadelmann-Nessler C; Fischer A; Boschert U; Häusler D; Weber MS
Acta Neuropathol; 2024 Apr; 147(1):75. PubMed ID: 38656399
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.
Skripuletz T; Miller E; Grote L; Gudi V; Pul R; Voss E; Skuljec J; Moharregh-Khiabani D; Trebst C; Stangel M
Brain Behav Immun; 2011 Nov; 25(8):1592-606. PubMed ID: 21635946
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
20. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
